483 Aurobindo Pharma Limited (Unit I) Feb 2019

483 Aurobindo Pharma Limited (Unit I) Feb 2019

Bapu Gaddam FDA, Dipesh Shah FDA$119.00 - Available Now

FDA investigators audited the Aurobindo Pharma Limited (Unit I) - Sangareddy, India facility and issued inspectional observations (via FDA 483) on 02 Feb 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 02 Feb 2019
  • Location: Sangareddy, India
  • FEI: 3004021253
Add To Cart